Clinical Trial Update: A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a neuroblastoma vaccine combined with beta-glucan; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-risk Neuroblastoma
• Neuroblastoma

Drugs mentioned

• Beta Glucan (beta-glucan)
• Neuroblastoma vaccine

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Neuroblastoma, High-risk Neuroblastoma | Phase 2 | Status: RECRUITING